[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345075-105":59,"doc-detail-345075-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cancer-like-fragmentomic-characteristics-of-somatic-variants-in-cell-free-dna","Cancer-Like Fragmentomic Characteristics of Somatic Variants in Cell-Free DNA","","Cell-free DNA (cfDNA) in plasma is produced through a non-random fragmentation process, yielding fragmentomic patterns linked to cellular origin. Somatic variant signatures in cfDNA are markedly different between non-cancer controls and cancer patients, while controls can still show cancer-like fragmentomic traits. These traits include reduced fragment size, lower DNA methylation, and altered end motif usage and nucleosome end distributions. The study links such aberrations to clonal hematopoiesis and finds stronger effects in patients. Using AI-integrated genomic, fragmentomic, and epigenomic features, the FreeSV and FreeSV+ models achieve high diagnostic performance across cancer types.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-like-fragmentomic-characteristics-of-somatic-variants-in-cell-free-dna/345075/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-like-fragmentomic-characteristics-of-somatic-variants-in-cell-free-dna/345075.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the paper report about somatic variant signatures in cfDNA between controls and cancer patients?","Question",{"text":113,"@type":114},"Somatic variant signatures in cfDNA differ substantially between non-cancer controls and cancer patients, suggesting tumor-associated signals are preserved in these variants.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why do the authors find cancer-like fragmentomic characteristics in some non-cancer controls?",{"text":118,"@type":114},"Even in controls, cfDNA molecules carrying somatic variants show cancer-like fragmentomic features, which are linked to somatic variants derived from clonal hematopoiesis.",{"name":120,"@type":111,"acceptedAnswer":121},"How do the AI models FreeSV and FreeSV+ contribute to cancer diagnosis?",{"text":122,"@type":114},"The FreeSV model uses somatic variant-associated features to reach AUCs across cancer types, while FreeSV+ additionally integrates genomewide features, increasing AUCs and highlighting the value of combined genomic and fragmentomic analyses.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},345075,1790160642,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Advanced Science    \n[www.advancedscience.com](www.advancedscience.com)  \n RESEARCH ARTICLE   \nCancer-Like Fragmentomic Characteristics of Somatic Variants in Cell-Free DNA  \nZhenyu Zhang1  Yunyun An1  Mengqi Yang1, 2  Yuqi Pan1, 3, 4  Xiaoyi Liu1, 3, 4  Fanglei Gong1, 3, 4  Huizhen Lin1, 3, 4 Bianbian Tang1  Yunxia Bai1  Xin Zhao5  Yu Zhao6  Changzheng Du7  Kun Sun1, 3   \n1 Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen, China  2 Department of Chemical and Biological Engineering, Division of Life Science, Hong Kong University of Science and Technology, Hong Kong SAR, China  3 Shenzhen Medical Academy of Research and Translation, Shenzhen, China  4 School of Life Sciences, Westlake University, Hangzhou, China  5 Hepato-Biliary Surgery Division, Shenzhen Third People’s Hospital, The Second Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China  6Molecular Cancer Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China  7 Cancer Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine,  \nTsinghua Medicine, Tsinghua University, Beijing, China Correspondence: Kun Sun ([sunkun@szbl.ac.cn](sunkun@szbl.ac.cn))  \nReceived: 4 August 2025  Revised: 31 December 2025  Accepted: 4 January 2026  \nKeywords: artificial intelligence | cancer diagnosis | end motif | epigenomics | liquid biopsy  \nABSTRACT  \nCell-free DNA (cfDNA) in plasma consists of short DNA fragments resulting from a non-random fragmentation process, with distinct fragmentomic characteristics that are related with their cellular origins. Here, we report that somatic variant signatures in cfDNA markedly differ between non-cancerous controls and cancer patients, indicating that tumor-associated signals are retained in these variants. Surprisingly, even in controls, cfDNA molecules harboring somatic variants exhibit cancer-like fragmentomic characteristics, such as reduced size, decreased DNA methylation, and altered end motif usages and distributions in the nucleosome structure. Further investigations suggest that such cancer-like traits are associated with somatic variants derived from clonal hematopoiesis. Importantly, these somatic variants-associated fragmentomic aberrations are more pronounced in cancer patients, enabling cancer diagnosis. In a large pan-cancer cohort, we utilize AI to integrate genomic, fragmentomic, and epigenomic features to develop diagnostic models named FreeSV and FreeSV+ . Leveraging somatic variant-associated features alone, the FreeSV model achieved area under the ROC curves (AUCs) between 0.81–0.92 across cancer types; however, when genomewide features are also included, the AUCs of FreeSV+ model substantially increased to 0.93–0.99 across cancer types, highlighting the significance of integrative genomic and fragmentomic analyses in cfDNA for cancer liquid biopsy.  \n1  Introduction  \nCirculating cell-free DNA (cfDNA) molecules in human plasma are small fragments of DNA that originate from dead cells (e.g., through apoptosis or necrosis) [1] . In non-cancerous subjects, cfDNA is primarily sourced from the hematopoietic system and liver [2–4]; in contrast, in cancer patients, the tumors release  \ncfDNA into plasma pool [5], which serves as a valuable analyte for non-invasive diagnostics, a process commonly referred to as“liquid biopsy” [6]. Tumor-derived cfDNA not only carry somatic mutations but also retain epigenomic modifications such as DNA methylation [7, 8] . Furthermore, recent studies indicate that the fragmentation patterns, termed “fragmentomics”, of tumorderived cfDNA differ from those of non-tumor-derived cfDNA.  \n\n| Zhenyu Zhang and Yunyun An contributed equally to this work.\u003Cbr>|\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s)","cbCaieEA6eTNptBI","https://ap.wps.com/l/cbCaieEA6eTNptBI","pdf",7949481,"English","# Abstract\n# Introduction\n## Cell-free DNA as a diagnostic analyte\n## Fragmentomics and end motif biology\n## Challenges in detecting tumor-derived variants\n## Sequencing depth, computational requirements, and confounders\n## Clonal hematopoiesis as a variant source","[{\"question\":\"What does the paper report about somatic variant signatures in cfDNA between controls and cancer patients?\",\"answer\":\"Somatic variant signatures in cfDNA differ substantially between non-cancer controls and cancer patients, suggesting tumor-associated signals are preserved in these variants.\"},{\"question\":\"Why do the authors find cancer-like fragmentomic characteristics in some non-cancer controls?\",\"answer\":\"Even in controls, cfDNA molecules carrying somatic variants show cancer-like fragmentomic features, which are linked to somatic variants derived from clonal hematopoiesis.\"},{\"question\":\"How do the AI models FreeSV and FreeSV+ contribute to cancer diagnosis?\",\"answer\":\"The FreeSV model uses somatic variant-associated features to reach AUCs across cancer types, while FreeSV+ additionally integrates genomewide features, increasing AUCs and highlighting the value of combined genomic and fragmentomic analyses.\"}]","Cancer-Like Fragmentomic Characteristics of Somatic Variants in Cell-Free DNA | PDF",1790056430,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c855871943286b3fdd44cc7b11c5f17d.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbbc4a882e1e5cf16b06b17946aa74e9.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a974ecf37dfed82bb2e7acc48f0d41d8.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e290a0972d0c932cd52ed46d068d615.webp",980,1287]